In the present study, use of anti-TNF agents was associated with a low muscle mass in RA patients, and the role of anti-TNF agent in muscle wasting should therefore be assessed prospectively in RA patients in future studies. The gene discussed is TNF; the disease is rheumatoid arthritis.